| Study Name |
Type of Study |
Total Patients |
Status |
Links |
| Vascular Intervention |
| BioMime Sirolimus Eluting Coronary Stent System |
| Sponsor Initiated Studies |
| meriT- 1 Study |
First-in-man |
30 |
Completed |
Know more |
| meriT-2 Study |
Observational study |
250 |
Completed |
Know more |
| meriT-3 Study |
Observational study |
1161 |
Completed |
Know more |
| meriT-V Study |
Randomized controlled trial |
256 |
Ongoing |
Know more |
| MILES-UK Registry |
UK Registry |
750 |
Ongoing |
Know more |
| MILES Global Registry |
Global Registry |
600 |
Ongoing |
Know more |
| BioMime Morph Sirolimus Eluting Coronary Stent System |
| Sponsor Initiated Studies |
| Morph India Study |
Prospective study |
450 |
Ongoing |
Know more |
| Morpheus Global Registry |
Global Registry |
400 |
Ongoing |
Know more |
| BioMime Morph BGM Study |
Prospective study |
100 |
Ongoing |
Know more |
| Investigator Initiated Studies |
| BioMime Morph Multicenter study |
Observational study |
362 |
Completed |
Know more |
| BioMime Morph study, Valencia, Spain |
Investigator initiated study |
50 |
Completed |
Know more |
| BioMime Morph study, Russia |
Investigator initiated study |
85 |
Completed |
Know more |
| BioMime Morph study, The Netherlands |
Investigator initiated study |
49 |
Completed |
Know more |
| BioMime Morph study, Spain |
Investigator initiated study |
628 |
Completed |
Know more |
| MeRes100 Bioresorbable Scaffold System |
| Sponsor Initiated Studies |
| MeRes-1 Study |
First-in-man |
108 |
Ongoing |
Know more |
| MeRes-1 Extend Study |
Global Study |
64 |
Ongoing |
Know more |
| Evermine 50 Everolimus Eluting Coronary Stent System |
| Sponsor Initiated Studies |
| Evermine 50 EES-1 Study |
Prospective study |
140 |
Ongoing |
Know more |
| Evermine 50 EES- KLES Study |
Observational study |
171 |
Completed |
Know more |
| Investigator Initiated Study |
| Evermine 50 EES- BGM Study |
Investigator initiated study |
251 |
Ongoing |
Know more |
| Metafor Sirolimus Eluting Coronary Stent System |
| Investigator Initiated Studies |
| Metafor study, Hyderguda |
Investigator initiated study |
127 |
Completed |
Know more |
| Metafor study, Hyderabad |
Investigator initiated study |
251 |
Completed |
Know more |
| Obtura VCD |
| Sponsor Initiated Study |
| Obtura VCD-1 Study |
Randomized controlled trial |
218 |
Ongoing |
Know more |
| MOZEC SEB PTCA Balloon Dilatation Catheter |
| Sponsor Initiated Study |
| MOZEC SEB PTCA-1 Study |
Prospective study |
123 |
Ongoing |
Know more |
| CREDENCE BtK |
| Sponsor Initiated Study |
| CREDENCE BtK-1 Study |
First-in-man |
30 |
Ongoing |
Know more |
| CREDENCE BRS |
| Sponsor Initiated Study |
| CREDENCE BRS-1 Study |
First-in-man |
30 |
Ongoing |
Know more |
| MELANGE BRS |
| Sponsor Initiated Study |
| MELANGE BRS-1 Study |
First-in-man |
45 |
Ongoing |
Know more |
| BioMime Branch |
| Sponsor Initiated Study |
| BioMime Branch-1 Study |
Randomized controlled trial |
183 |
Ongoing |
Know more |
| Dafodil Pericardial Bioprosthesis |
| Dafodil-1 Study |
First-in-man |
136 |
Followup Ongoing |
Know more |
| Myval TAVR |
| Sponsor Initiated Study |
| MyVal-1 Study |
First-in-man |
30 |
Ongoing |
Know more |
| Promesa DES |
| Sponsor Initiated Study |
| Promesa DES-1 Study |
First-in-man |
30 |
Ongoing |
Know more |
| PAXIMUS PEB PTA |
| Sponsor Initiated Study |
| PAXIMUS PEB PTA RCT-1 Study |
Randomized controlled trial |
280 |
Planned |
Know more |
| Endo-surgery |
| MITSU Polyglactin 910 Suture |
| Sponsor Initiated Study |
| MITSU Polyglactin 910 Suture |
Randomized controlled trial |
122 |
Completed |
Know more |
| MITSU AB Polyglactin 910 Suture |
| Sponsor Initiated Study |
| MITSU AB Polyglactin 910 Suture |
Randomized controlled trial |
122 |
Completed |
Know more |
| MIRUS Disposable Hemorrhoids Stapler |
| Sponsor Initiated Study |
| MIRUS Disposable Hemorrhoids Stapler |
Prospective study |
82 |
Completed |
Know more |
| Investigator Initiated study |
| MIRUS Stapler, Ranchi |
Retrospective study |
150 |
Completed |
Know more |
| Fiona IUD |
| Sponsor Initiated Study |
| Fiona-1 |
Prospective study |
309 |
Ongoing |
Know more |
| MERIZELLE ORC U.S.P |
| Sponsor Initiated Study |
| MERIZELLE-1 |
Prospective study |
185 |
Ongoing |
Know more |
| Diagnostic |
| EXIMO Blood Glucose Monitoring System |
| Sponsor Initiated Study |
| EXIMO |
Prospective study |
1005 |
Completed |
Know more |
| Orthopedic |
| Latitud Hip Replacement System |
| Sponsor Initiated Study |
| Latitud 180 study |
Prospective study |
180 |
Ongoing |
Know more |
| PEEK-OPTIMA femoral component |
| Sponsor Initiated Study |
| PEEK India |
First-in-man |
34 |
Planned |
Know more |
| ETERNAL Total Knee Replacement System |
| Sponsor Initiated Study |
| ETERNAL-1 study |
First-in-man |
60 |
Planned |
Know more |
| Freedom Total Knee System |
| Sponsor Initiated Study |
| Freedom 400 study |
Prospective study |
400 |
Ongoing |
Know more |
| Freedom 450 study, UK |
Prospective study |
450 |
Planned |
Know more |
| Investigator Initiated Study |
| Freedom study, Amritsar, India |
Investigator initiated study |
158 |
Completed |
Know more |
